Effects of the angiotensin receptor-neprilysin inhibitor/sacubitril-valsartan administration on quality of life and outcome in heart failure with reduced ejection fraction: a meta analysis

被引：0
|
作者：
Dewi, Kadek Intan Murti [1 ]
Pintaningrum, Yusra [1 ]
机构：
[1] Mataram Univ, Dept Cardiovasc Med, Fac Med, Mataram, Indonesia
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / 0F期
关键词：
HFrEF; sacubitril-valsartan; quality of life;
D O I：
10.1093/eurheartjsupp/suab123.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M7
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Positive Recommendation for Angiotensin Receptor-Neprilysin Inhibitor: First Medication Approval for Heart Failure Without Reduced Ejection Fraction
    Howlett, Jonathan G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (04) : 528 - 530
  • [22] Coronary Flow Reserve Changes after Angiotensin Receptor-Neprilysin Inhibitor Treatment in Heart Failure with Reduced Ejection Fraction
    Karaayvaz, Ekrem Bilal
    Guz, Goksel
    ACTA CARDIOLOGICA SINICA, 2023, 39 (06) : 871 - 878
  • [23] Effects of Sacubitril-valsartan Compared with Enalapril on Arterial Hemodynamics, Cardiac Remodeling, and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction
    Desai, Akshay S.
    Solomon, Scott D.
    Shah, Amil M.
    Claggett, Brian L.
    Fang, James C.
    Izzo, Joseph
    Abbas, Cheryl A.
    Rocha, Ricardo A.
    Mitchell, Gary F.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (11) : 938 - 938
  • [24] Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience
    Ferreira, F. A. C.
    Cristina, S.
    Raposo, A. F.
    Albuquerque, E. M.
    Nabais, I.
    Matias, C. S.
    Nogueira, M. A.
    Vasconcellos, R. C. A.
    Proenca, G. M. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 229
  • [25] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
    Sandhu, Alexander T.
    Ollendorf, Daniel A.
    Chapman, Richard H.
    Pearson, Steven D.
    Heidenreich, Paul A.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (10) : 681 - +
  • [26] Sympathoinhibitory effect of sacubitril-valsartan in heart failure with reduced ejection fraction: A pilot study
    Bunsawat, Kanokwan
    Ratchford, Stephen M.
    Alpenglow, Jeremy K.
    Stehlik, Josef
    Smith, Adam S.
    Richardson, Russell S.
    Wray, D. Walter
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2021, 235
  • [27] Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
    Arbel, Ronen
    Azab, Abed N.
    Oberoi, Mansi
    Aboalhasan, Enis
    Star, Artyom
    Elhaj, Khaled
    Khalil, Fouad
    Alnsasra, Hilmi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Arbel, Ronen
    Oberoi, Mansi
    Alnsasra, Hilmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 628 - 628
  • [29] FRAILTY AND UPTAKE OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR FOR HEART FAILURE WITH REDUCED EJECTION FRACTION
    Ko, Darae
    Lee, Yu-Chien
    Lin, Kueiyu Joshua
    Cheng, Susan
    Patorno, Elisabetta
    Glynn, Robert J.
    Tsacogianis, Theodore
    Kim, Dae Hyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 521 - 521
  • [30] Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction
    Lee, Yu-Chien
    Lin, Joshua K.
    Ko, Darae
    Cheng, Susan
    Patorno, Elisabetta
    Glynn, Robert J.
    Tsacogianis, Theodore
    Kim, Dae Hyun
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (10) : 3110 - 3121
12345